The effect of genistein on anion secretion via cystic fibrosis transmembrane conductance regulator (CFTR) in cultured rat cauda epididymal epithelia was studied by short-circuit current (Isc) technique. Genistein added apically stimulated a concentration-dependent rise in Isc due to Cl Ϫ and HCO 3 Ϫ secretion. The genistein-induced Isc was observed in basolaterally permeabilized monolayers, suggesting that the Isc response was mediated by the apical anion channel. The response could be blocked by the nonspecific Cl Ϫ channel blocker, diphenylamine-2-carboxylate (DPC), but not by the Ca 2؉ -activated Cl Ϫ channel blocker, 4,4-diisothiocyanostilbene-2,2-disulfonic acid (DIDS). Genistein did not increase intracellular cAMP, but H-89, a protein kinase A inhibitor, completely abolished the Isc response to genistein. Moreover, pretreatment of the tissues with MDL-12330A, an adenylate cyclase inhibitor, markedly attenuated the Isc response to genistein, but the response was restored upon the addition of exogenous cAMP. Ca 2؉ , protein kinase C, tyrosine kinase, and protein phosphatase signalling pathways were not involved in the action of genistein. It is speculated that genistein stimulates anion secretion by direct interaction with CFTR. This requires a low level of phosphorylation of CFTR by basal protein kinase A activity. It is suggested that genistein may provide therapeutic benefit to male infertility associated with cystic fibrosis.
INTRODUCTION
Electrolyte transport by epididymal epithelium is important in creating a favorable microenvironment for sperm maturation. The fluidity of this environment has been shown to be regulated by a variety of neurohumoral agents [1] [2] [3] [4] , most of which stimulate fluid secretion via the cAMP/protein kinase (PK) A signaling pathway converging on the cAMP-activated Cl Ϫ channel in the apical membrane of the principle cells. This Cl Ϫ channel is known as cystic fibrosis transmembrane conductance regulator (CFTR), which is the key element in fluid secretion by epididymal epithelium.
Cystic fibrosis (CF) is a common lethal genetic disease affecting mostly Caucasians. It is caused by mutation of the CFTR gene in various exocrine tissues. The resulting loss of cAMP-driven anion/fluid secretion may be responsible for the obstruction or agenesis of the vas deferens seen in men with CF [5] . Recently, genistein and flavonoids with similar structures have been reported to activate CFTR in the airway epithelium [6] , colonic epithelium [7] , and ventricular myocytes [8] without raising the cAMP level. Nevertheless, the mechanism of action of genistein remains controversial. As the epididymis is highly dependent on CFTR for its function, it is of interest to investigate the effect of genistein on anion secretion in cultured rat epididymal epithelia. The therapeutic potential of genistein in male infertility related to CF is discussed in this paper.
MATERIALS AND METHODS

Materials
Minimum essential medium Eagle (MEM), fetal bovine serum, and nonessential amino acids were purchased from Gibco Laboratories (Grand Island, NY). Penicillin/streptomycin, Hanks' balanced salt solution (HBSS), sodium pyruvate, 5␣-dihydrotestosterone, trypsin, collagenase I, genistein, frusemide, acetazolamide, nystatin, cAMP, and 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid (DIDS) were from Sigma (St. Louis, MO). Thapsigargin was from Research Biochemicals International (Natick, MA); and Calbiochem (San Diego, CA) was the source for the adenylate cyclase inhibitor MDL-12330, the protein kinase A inhibitor H-89, bisindolylmaleimide, phorbol 12-myristate 13-acetate (PMA), calyculin A, tyrphostin A47, and diphenylamine-2-carboxylate (DPC). The immunoassay kit for cAMP was purchased from R & B Systems (Minneapolis, MN).
Solutions
Krebs-Henseleit solution had the following composition: NaCl, 117 mM; KCl, 4.7 mM; KH 2 PO 4 , 1.2 mM; MgSO 4 ·7H 2 O mM, 1.2; CaCl 2 ·2H 2 O, 2.56 mM; NaHCO 3 , 24.8 mM; and glucose, 11.1 mM. This solution had a pH of 7.4 when gassed with 95% O 2 , 5% CO 2 . In Cl Ϫ -free solution, NaCl, KCl, and CaCl 2 were replaced by sodium gluconate, potassium gluconate, and calcium gluconate, respectively. When HCO 3 Ϫ -free solution was used, NaHCO 3 was replaced with NaCl, and the solution was buffered with 10 mM Hepes with a pH of 7.4 when gassed with 100% O 2 . In the Cl Ϫ -and HCO 3 Ϫ -free solutions, NaCl and NaHCO 3 were replaced by sodium gluconate, KCl by potassium gluconate, and CaCl 2 by calcium gluconate. The solution was buffered with 10 mM Hepes with a pH of 7.4 when gassed with 100% O 2 . In all solutions, the osmolarity was adjusted to 290 mosmol/L with D-mannitol if necessary.
Tissue Culture Technique
The tissue culture procedures have been described previously [1, 9] . Immature male Sprague-Dawley rats weighing 150 g were used as a source of cauda epididymidis. They were killed by CO 2 inhalation. The epididymis was dissected out, finely chopped with scissors, and treated suc- cessively with 0.25% (w:v) trypsin and 0.1% (w:v) collagenase. The disaggregated cells were suspended in MEM containing nonessential amino acids (0.1 mM), sodium pyruvate (1 mM), glutamine (4 mM), 5␣-dihydrotestosterone (1 nM), 10% fetal bovine serum, penicillin (100 IU/ml), and streptomycin (100 g/ml), and seeded into the wells of Millipore (Bedford, MA) filter assemblies with a diameter of 0.4 cm 2 (cell concentration 10 5 cells/ml, plating density 5 ϫ 10 4 cells/cm 2 filter) floating on 15 ml of culture medium. Cultures were incubated in 5% CO 2 for 3 days at 32ЊC. Thereafter, the monolayers reached confluence and were ready for the measurement of short-circuit current (Isc). This culture method has been shown to yield epithelia with morphology resembling that of the intact rat epididymis and with the major cell type being principal cells [10] .
Isc Measurement
Confluent epididymal monolayers were clamped between two halves of a Ussing chamber (World Precision Instruments, Inc., New Haven, CT) with a 0.6-cm 2 window. The tissue was short-circuited with a voltage-clamp amplifier (DVC 1000; World Precision Instruments). The Isc was displayed on a pen recorder. Transepithelial resistance was obtained from Ohm's law by clamping the tissue intermittently at a voltage at 0.1-0.3 mV displaced from zero. Epithelia with transepithelial resistance of less than 300 ⍀ cm 2 were discarded. Usually two channels of the amplifier were used simultaneously on parallel monolayers so that studies could be made under control and experimental conditions. In the majority of cases, the monolayers were bathed on both sides with Krebs-Henseleit solution, gassed with 95% O 2 /5% CO 2 , and warmed to 32ЊC.
Measurement of cAMP
Rat epididymal cell monolayers were grown on 24-well plates (Costar, Cambridge, MA). After reaching confluence, they were washed twice with Krebs-Henseleit solution and then incubated in 0.5 ml of the same buffer containing isobutylmethylxanthine (IBMX, 1 mM) for 10 min at 32ЊC. Genistein was added to the wells and incubated for an additional 10 min. The reaction was terminated by adding 10 l (60% w:v) perchloric acid to each well. The content of each well was mixed thoroughly and transferred to a 1.5-ml microcentrifuge tube and was then centrifuged at 10 000 ϫ g for 5 sec. Supernatant (300 l) was neutralized by KOH (1 M). The mixture (100 l) was assayed for cAMP by an immunoassay kit.
Statistical Analysis
Results are expressed as means Ϯ SEM. Comparisons between groups of data were analyzed by one-way ANOVA followed by Duncan's multiple-range procedure (for comparison of cAMP levels) or Student's unpaired t-test. A P value of less than 0.05 was considered statistically significant.
RESULTS
Effect of Genistein on the Isc
When bathed in normal Krebs-Henseleit solution, the cultured epididymal epithelia exhibited a transepithelial potential difference of 2.3 Ϯ 0.1 mV (n ϭ 118 monolayers from 10 different cell preparations), a basal Isc of 5.4 Ϯ 0.2 A/cm 2 (n ϭ 118 monolayers from 10 different cell preparations), and a transepithelial resistance of about 500 ⍀ cm 2 . When added to the apical side, genistein elicited a dose-dependent increase in Isc (Fig. 1 , B and C). However, no change in Isc was observed when genistein was added to the basolateral side (Fig. 1A) . The maximal Isc response to genistein was 6.25 Ϯ 0.32 A/cm 2 , and the median effective concentration was 10 M. In all subsequent experiments, genistein was added to the apical side of the tissue. Figure 2 shows the concentration-response curves of genistein when anions in the bathing media were omitted. In Cl Ϫ -free solution (HCO 3 Ϫ -solution), the threshold dose and the maximum Isc response to genistein were 10 M and 1.53 A/cm 2 (76% inhibition of the response in normal Krebs-Henseleit solution), respectively. In HCO 3
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Ϫ -free solution (Cl Ϫ -solution), the threshold dose and the maximum response were 1 M and 3.41 A/cm 2 (45% inhibition), respectively. The Isc response to genistein when both anions were omitted from the bathing solution was negligible.
Involvement of Apical CFTR
To investigate whether the genistein-induced Isc response was mediated by activation of the apical Cl Ϫ -channel or the basolaterally placed transporters or Na ϩ -K ϩ ATPase, the pore-forming antibiotic, nystatin (500 M), was used to selectively permeabilize the basolateral membrane. Solutions were used to achieve a Cl Ϫ gradient of 40: 120 mM (apical to basolateral) across the epithelium after the active transport mechanism was disabled by permeabilization of the basolateral membrane. As shown in Figure  3 , an Isc response to genistein (5.00 Ϯ 0.72 A/cm 2 ) was observed after pretreatment with nystatin for 45-60 min. At the plateau of the response, basolateral addition of frusemide (100 M), an inhibitor of the Na ϩ /K ϩ /2Cl Ϫ symport, did not inhibit the Isc, confirming that the basolateral membrane had been successfully permeabilized by nystatin. Apical application of DPC (1 mM) completely blocked the Isc response to genistein, indicating the involvement of the apical Cl Ϫ channel. The effects of different Cl Ϫ channel blockers were examined to investigate the types of Cl Ϫ channel activated by genistein. At the plateau phase of the Isc response to genistein, DPC (1 mM) or DIDS (100 M) was added apically to determine whether the Isc response to genistein was due to activation of the cAMP-activated channel (CFTR) or the Ca 2ϩ activated channel. As shown in Figure 4 , DPC completely blocked the Isc response to genistein whereas DIDS, at a concentration that should have inhibited the Ca 2ϩ -activated Cl Ϫ channel in the epididymis [11] , did not exert any significant inhibitory effect.
Effect of Thapsigargin on the Genistein-Induced Isc
Figure 5B shows that pretreatment with thapsigargin (1 M), a microsomal Ca 2ϩ -ATPase inhibitor, elicited an Isc response due to the release of Ca 2ϩ from internal calcium store. When the current had returned to the basal level, addition of genistein produced an Isc response that was not significantly different from that produced by the same concentration of genistein without prior treatment of thapsigargin (Fig. 5A) . 
Cyclic AMP Level After Genistein
Immunoassays were performed to study the effects of genistein on intracellular cAMP level in the epididymal epithelia. The results are shown as Figure 6 . The intracellular cAMP content under basal conditions and after incubation with genistein (20 M) were 47.6 Ϯ 9.6 pmol/well (n ϭ 6) and 51.0 Ϯ 15.0 pmol/well (n ϭ 5), respectively. The difference was not statistically significant. However, forskolin, serving as a positive control, stimulated a rise in cAMP level to 130.2 Ϯ 14.4 pmol/well (n ϭ 5; P Ͻ 0.01).
Effects of Inhibitors of PKA, PKC, and Adenylate Cyclase
To further elucidate the involvement of cAMP/PKA pathway in the response to genistein, the effect of the PKA inhibitor, H-89, was examined. As shown in Figure 7 , the Isc response to genistein could be completely abolished upon pretreatment with H-89.
Another set of experiments was performed to examine the role of phosphorylation of CFTR by PKA in the action of genistein. After permeabilization of the basolateral membrane by nystatin, the Isc response to genistein could be blocked by pretreatment with MDL-12330A (50 M), a specific adenylate cyclase inhibitor that would have depleted intracellular cAMP (Fig. 8B) . Nevertheless, subsequent addition of cAMP (5 M), which had very little ef- fect on Isc at this concentration, fully restored the Isc response to genistein (Fig. 8, A and C) .
To study the involvement of PKC in the Isc response to genistein, the effect of the PKC inhibitor bisindolylmaleimide (BIS) was examined. As shown in Figure 9 , pretreatment with BIS (1 M) did not affect the Isc response to genistein but reduced most of the Isc response to the PKC activator, PMA (1 M).
Effects of Tyrphostin A47 and Calyculin A
As shown in Figure 10 , tyrphostin A47 (20 or 200 M), at concentrations known to inhibit tyrosine kinase, and calyculin A (20 or 200 nM), at concentrations known to inhibit protein phosphatase (PPase), did not affect the basal Isc in rat epididymal epithelium, nor did they affect the Isc response to genistein.
DISCUSSION
The study reported here demonstrated that genistein stimulated a dose-dependent rise in Isc in cultured rat epididymal epithelium. Experiments with ion replacement (Fig. 2) and anion channel blockers (Fig. 4) indicated that the rise in Isc was mediated by anion (chloride and bicarbonate) secretion. Moreover, the genistein-induced Isc was found to be inhibited by basolateral addition of acetazolamide (inhibitor of bicarbonate transport) or frusemide (inhibitor of chloride transport) (data not shown), lending further support to the contention that genistein stimulates anion secretion. The model of anion secretion in rat epididymis has been well established [12] . It involves the interplay of the Na ϩ /K ϩ pump, Na ϩ /K ϩ /2Cl Ϫ symport, the Na ϩ /H ϩ exchanger, and the K ϩ channel located on the basolateral membrane, and the anion channels placed on the apical membrane. It could be argued that the increase in anion secretion by genistein could be due to activation of the basolaterally placed components rather than the apical anion channels. However, results obtained from epithelia with basolateral membranes permeabilized by nystatin provided evidence that the effect of genistein was on apical anion channels. Two major types of Cl Ϫ channels in the epididymal epithelium have been reported to show differential sensitivities to Cl Ϫ channel blockers. DPC, a nonspecific Cl Ϫ channel blocker blocks both the cAMP-activated and the Ca 2ϩ -activated Cl Ϫ channels, whereas DIDS, a Ca 2ϩ -activated Cl Ϫ channel blocker blocks only the Ca 2ϩ -activated Cl Ϫ channel [12] . The Isc response to genistein could be blocked by DPC rather than DIDS, indicating the involvement of cAMP-activated Cl Ϫ channel (CFTR) in the action of genistein. In addition, thapsigargin, a microsomal Ca 2ϩ -ATPase inhibitor that leads to the depletion of Ca 2ϩ store, did not affect the genistein-induced Isc. The results support the notion that intracellular Ca 2ϩ plays a negligible role in the response to genistein.
There has been much debate on the mechanism underlying the activation of CFTR by genistein. Since genistein is a well-characterized tyrosine kinase inhibitor in multiple cell types, it was initially thought to activate CFTR by inhibition of protein tyrosine kinase [7, 13] . However, the present study demonstrated that tyrphostin A47, at a dose found to inhibit tyrosine kinase in colonic cells [7] , was unable to mimic the action of genistein (Fig. 10 ). Similar observations in other epithelia [14] [15] [16] strengthen the idea that genistein activates CFTR via a tyrosine kinase-independent pathway.
Genistein stimulated anion secretion without raising intracellular cAMP (Fig. 7) . This finding ruled out the possibility that genistein activated adenylate cyclase. Instead, constitutive phosphorylation of CFTR by PKA might be required for the action of genistein as inhibition of PKA by H-89 inhibited the genistein-induced Isc response (Fig. 8) . Moreover, in nystatin-permeabilized monolayers, genistein did not stimulate Isc when the intracellular cAMP level had been previously suppressed by the adenylate cyclase inhibitor MDL-12330A. Replenishment of a low level of cAMP (5 M), however, restored the normal response to genistein (Fig. 9) .
It is generally held that the CFTR activity stimulated by PKA can be reversed by dephosphorylation with PPase. Two distinct PPases have been proposed to dephosphorylate different phosphorylation sites on CFTR [17, 18] . The activation site is dephosphorylated by PPase 2A (calyculin A-sensitive), whereas the modulation site is dephosphorylated by PPase 2C (calyculin A-insensitive). Illek et al. [16] suggested that inhibition of PPase by genistein might prevent dephosphorylation and enhance CFTR activity. However, our data demonstrated that calyculin A, at concentrations found to inhibit PPase 2A [17] , did not affect the response to genistein (Fig. 10) , casting doubt on the involvement of PPase 2A in the regulation of CFTR activity in epididymal epithelium. Genistein may act via inhibition of PPase 2C [17] [18] [19] . However, this possibility awaits fur-ther investigation when specific PPase 2C inhibitors become available in the future. Although it is generally believed that phosphorylation by PKA is the principle pathway regulating the gating of CFTR, CFTR can also be phosphorylated by PKC [20] . Constitutive PKC phosphorylation has been found to be a prerequisite for the subsequent activation by PKA [21] . Previous work has provided evidence that PKC plays an important role in electrolyte secretion by the epididymis [22] . In our present study, pretreatment with BIS, a specific PKC inhibitor, did not reduce the Isc response to genistein (Fig. 9) . Therefore, the stimulatory effect of genistein is unlikely to be mediated by PKC.
CFTR belongs to the ATP-binding cassette superfamily of transporters. CFTR is activated by phosphorylation of the R domain, and its channels are gated by the hydrolysis of ATP in two nucleotide binding domains (NBDs). NBD1 controls the opening whereas NBD2 controls the closing [23] . It was proposed that genistein may bind directly to the ATP-binding site in NBD2 to prevent closure of CFTR channels [24] [25] [26] . It is known that the binding and hydrolysis of ATP in NBDs require phosphorylation of the R domain [27] [28] [29] [30] . Our finding that CFTR must be in a phosphorylated form before genistein can exert its effect is consistent with a direct interaction of genistein with CFTR in the epididymis.
CF results in defective anion and fluid secretion in various epithelia such as the airway, the pancreatic duct, and the gastrointestinal tract. In the epididymis, defective fluid transport leads to male infertility [5] . At the present time, there are two major approaches in the treatment of CF. Gene therapy can be applied to transfer the normal CFTR gene into the affected cells [31] . Another strategy involves the use of pharmacological agents to modulate ion channels other than CFTR. For instance, amiloride and uridine-5Ј-triphosphate have been used to reduce Na ϩ (water) reabsorption and increase Ca 2ϩ -driven anion (water) secretion, respectively [32] . Although much of the mutated CFTR is degraded during processing (e.g., ⌬F508) [33] , recent studies showed that a low level of mutated CFTR protein can still reach the apical membrane [34] , in which they are amenable to pharmacological intervention. In heterologous cell expression systems, genistein has been shown to potentiate the cAMP-dependent activation of G551D-CFTR [35] and ⌬F508-CFTR [19, 36] , the most common mutations in CF. Although the development of pharmacological agents targeted at the CFTR is still at an early stage, our present demonstration that genistein stimulates anion secretion in the epididymis (probably by direct interaction with CFTR) has led to the premise that genistein may be of therapeutic benefit in the reversal of epididymal anomalies in CF men. This may offer new hope for men with CF to father children. However, before such measures are taken, genetic screening and counseling for the men and their partners are mandatory to safeguard the offspring from the risk of clinical CF [5] .
